Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

East Hanover, New Jersey


Purpose:

This study evaluates the efficacy and safety of 2 doses of pimecrolimus (0.3% and 1%) ophthalmic suspension in a moderate to severe population of keratoconjunctivitis sicca (KCS, dry eye syndrome) patients.


Criteria:

Inclusion Criteria: - History of artificial tear use - Moderate to severe signs of dry eye - Moderate to severe ocular discomfort Exclusion Criteria: - Patients with uncontrolled systemic or ocular diseases. - Have any history of refractive surgery - Use any topical ocular medications other than those dispensed for the study, during the study Other protocol-defined exclusion criteria may apply.


NCT ID:

NCT00128245


Primary Contact:

Principal Investigator
Gary Foulks, Dr.
University of Louisville, USA


Backup Contact:

N/A


Location Contact:

East Hanover, New Jersey
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: December 11, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.